D268-0065 Screening compound: N-(4-{1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2,5-oxadiazol-3-yl)acetamide

D268-0065 Screening compound: N-(4-{1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2,5-oxadiazol-3-yl)acetamide
D268-0065 Screening compound: N-(4-{1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2,5-oxadiazol-3-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D268-0065
N-(4-{1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2,5-oxadiazol-3-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D268-0065

Molecular Formula

C15H13N7O3 (C15 H13 N7 O3)

Compound Name

N-(4-{1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1,2,5-oxadiazol-3-yl)acetamide

IUPAC name

N-(4-{1-[(5-methyl-134-oxadiazol-2-yl)methyl]-1H-13-benzodiazol-2-yl}-125-oxadiazol-3-yl)acetamide

SMILES

CC(Nc1nonc1-c1nc(cccc2)c2n1Cc1nnc(C)o1)=O

InChI

InChI=1S/C15H13N7O3/c1-8(23)16-14-13(20-25-21-14)15-17-10-5-3-4-6-11(10)22(15)7-12-19-18-9(2)24-12/h3-6H,7H2,1-2H3,(H,16,21,23)

InChI Key

YWYKHKXULPPWLE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01785731

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

339.31

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.534

Distribution Coefficient, logD

1.503

Water Solubility, LogSw

-2.07

Polar Surface Area

99.866

Acid Dissociation Constant (pKa)

9.19

Base Dissociation Constant (pKb)

6.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

D268-0065 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Angiogenesis library (14822 compounds)

Anti-Inflammatory Library (24602 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Immune system

References: we are preparing a list of scientific research reports with D268-0065 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D268-0065?
Check Price and Availability of D268-0065, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D268-0065 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D268-0065
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D268-0065
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D268-0065 available by request